Hyloris Pharmaceuticals Stock Quote 0AB6 - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
UK
LSE
Hyloris Pharmaceuticals Sa (0AB6) Quote

Hyloris Pharmaceuticals Sa (0AB6)

0.00

0.00

(0.00%)

Closed April 28 11:30AM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

-

Bid

0.00

Ask

0.00

Volume

10

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

28,000,000

Dividend Yield

-

PE Ratio

-20.79

Earnings Per Share (EPS)

-0.56

Revenue

-

Net Profit

-15.76M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hyloris.com

Headquarters

Liege, Liege, Bel

Founded

1970

Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was 0.00 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. The market capitalization of Hyloris Pharmaceuticals is 327.60 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -20.79.

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M

janice shell

janice shell 4 minutes ago

Doubtful SFIO will be around much longer

Doubtful SFIO will be around much longer 5 minutes ago

Considering the fact the BBB is SFIO you will not get any kind of response.

arizona1

arizona1 5 minutes ago

And he seems resentful about not having gone to college.

Perhaps if he had, his stifled world view would have been different.

RMS555

RMS555 6 minutes ago

this company is all fluff....Can you find me a CashX kiosk? There are supposed to be 100 operating CashX kiosks in Mexico but only 1 address provided!

Do some proper DD on XALL before saying its profitable, its a share printing company. Dilution and no results!

Xalles h

sspalmo

sspalmo 6 minutes ago

I believe I saw something stating that they were going to apply to FINRA to have the Preferred Class A shares be eligible for conversion to common shares, but I can't find it at the moment.

surfer44

surfer44 8 minutes ago

Thanks Murray. I like that song alot. I had to look up his bio...

Background information
Birth name Gary D. Davis
Also known as Blind Gary Davis
Born April 30, 1896
Laurens, South Carolina, U.S.
Died May 5, 1972 (aged 76)
Hammo

carlson

carlson 8 minutes ago

I like the last paragraph!

newmedman

newmedman 9 minutes ago

yeah, well I prefer working my balls off. I don't need to run to prove my meddle although I have been around others who have. My college buddy's wife was very sick and became an accomplished runner after having two kids. She's little too, maybe 5'3 but she's a champ in my book. I don't kee

janice shell

janice shell 9 minutes ago

And he seems resentful about not having gone to college. But he could have, without much trouble. Back then, kids--boys, especially--could work their way through college pretty easily.

Aimless Blade

Aimless Blade 9 minutes ago

This is the way.

WALLnut

WALLnut 9 minutes ago

Why didn't you buy (accumulate) in the .05s when we sat there for 2 years? And what happened to your 8 ball friend?

RMS555

RMS555 9 minutes ago

KEGS can always brew more as long as there are ingredients.... KEGS brews and bottles their Award Winning 1812 Amber Ale at their 13,000 square foot Brewery!

Good Luck To All Shareholders of KEGS!

Lets Go KEGS! More Good News!

https://www.otcmarkets.com/s

oystersnbeer

oystersnbeer 9 minutes ago

It’s called ,
Trump Derangement Syndrome.

koolmc

koolmc 10 minutes ago

agreed this post is for those who are actually playing the stock.

JackSchmidt

JackSchmidt 10 minutes ago

I know several who where there that are no longer sure what exists there (IV) as you can no longer see anything but a sign in page. Not going to join something I dont even know what it is anymore... Are you a member there? Has it changed? what is going on there? How the heck are they supposed to get

sharpie510

sharpie510 11 minutes ago

https://twitter.com/sharpie510/status/1784764210754572291

https://twitter.com/ThomasOwenMcCa1/status/1784767891709231579

Dodger1

Dodger1 11 minutes ago

Well if you base currency off Decentralization...then yes...it would be valuable.

In other words..if it wasn't about control but rather Merit based on hard work and ethics...like what we all should be. But to the contrary, I believe it not to be true.

Go $AABB

koolmc

koolmc 11 minutes ago

you can't reason with em he's bit of a nutter.

joe botts

joe botts 11 minutes ago

May 7 .... still be REVOKED

joe botts

joe botts 12 minutes ago

It will still be REVOKED

tr8dervic

tr8dervic 12 minutes ago

That's racin' luck...

fink

fink 12 minutes ago

Nice bump on the close.

I'm still laying low on the BID.
450k float can crash and burn fast. Plus I need some on the cheap LOL

fink

fink 15 minutes ago

Hope so. My account get big moves from this one.

.0045 is still in play

Hyloris Pharmaceuticals

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions